4-Fluoro-3,5-diMethoxybenzoic Acid
|
- $45 - $895
- Product name: 4-Fluoro-3,5-diMethoxybenzoic Acid
- CAS: 1785030-01-4
- MF: C9H9FO4
- MW: 200.16
- EINECS:
- MDL Number:MFCD28348659
- Synonyms:4-Fluoro-3,5-diMethoxybenzoic Acid;_x005f\r4-Fluoro-3，5-dimethoxybenzoic Acid;Benzoic acid, 4-fluoro-3,5-dimethoxy-
4 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 10mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number0123EA
- Product description4-Fluoro-3,5-dimethoxybenzoicAcid
- Packaging1g
- Price$532
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12131376
- Product description4-Fluoro-3,5-dimethoxybenzoicacid 97%
- Packaging1g
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12131376
- Product description4-Fluoro-3,5-dimethoxybenzoicacid 97%
- Packaging5g
- Price$895
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberF402710
- Product description4-Fluoro-3,5-dimethoxybenzoicAcid
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 0123EA | 4-Fluoro-3,5-dimethoxybenzoicAcid | 1g | $532 | 2021-12-16 | Buy |
| Crysdot | CD12131376 | 4-Fluoro-3,5-dimethoxybenzoicacid 97% | 1g | $330 | 2021-12-16 | Buy |
| Crysdot | CD12131376 | 4-Fluoro-3,5-dimethoxybenzoicacid 97% | 5g | $895 | 2021-12-16 | Buy |
| TRC | F402710 | 4-Fluoro-3,5-dimethoxybenzoicAcid | 10mg | $45 | 2021-12-16 | Buy |
Properties
Boiling point :356.9±37.0 °C(Predicted)
Density :1.298±0.06 g/cm3(Predicted)
pka :3.90±0.10(Predicted)
Density :1.298±0.06 g/cm3(Predicted)
pka :3.90±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|